Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SCML1 mRNA | CTD | PMID:22079256 | 2-hydroxypropanoic acid | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of SCML1 mRNA | CTD | PMID:30851411 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCML1 mRNA | CTD | PMID:28628672 | acrylamide | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of SCML1 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | SCML1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SCML1 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SCML1 mRNA | CTD | PMID:23724009 | avobenzone | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | avobenzone results in increased expression of SCML1 mRNA | CTD | PMID:31016361 | azathioprine | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of SCML1 mRNA | CTD | PMID:22623647 | belinostat | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | belinostat results in increased expression of SCML1 mRNA | CTD | PMID:26272509 and PMID:27188386 | belinostat | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCML1 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | affects methylation | ISO | SCML1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SCML1 5' UTR and Benzo(a)pyrene affects the methylation of SCML1 exon | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | SCML1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SCML1 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol F | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCML1 mRNA | CTD | PMID:28628672 | CGP 52608 | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SCML1 gene] | CTD | PMID:28238834 | copper(II) sulfate | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SCML1 mRNA | CTD | PMID:19549813 | CU-O LINKAGE | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | cupric oxide results in increased expression of SCML1 mRNA | CTD | PMID:22077320 | cyclosporin A | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SCML1 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCML1 mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of SCML1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SCML1 mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | elemental selenium | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | entinostat | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | entinostat results in increased expression of SCML1 mRNA | CTD | PMID:27188386 | genistein | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Genistein results in increased expression of SCML1 mRNA | CTD | PMID:26865667 | hydralazine | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in decreased expression of SCML1 mRNA | CTD | PMID:17183730 | indometacin | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCML1 mRNA | CTD | PMID:28628672 | methylmercury chloride | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SCML1 mRNA | CTD | PMID:28001369 | panobinostat | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCML1 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SCML1 mRNA | CTD | PMID:26272509 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SCML1 mRNA | CTD | PMID:27153767 | potassium chromate | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SCML1 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of SCML1 mRNA | CTD | PMID:22079256 | rac-lactic acid | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of SCML1 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | selenium atom | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | sunitinib | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SCML1 mRNA | CTD | PMID:31533062 | tert-butyl hydroperoxide | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of SCML1 mRNA | CTD | PMID:15336504 | trichostatin A | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SCML1 mRNA | CTD | PMID:24935251 more ... | trichostatin A | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCML1 mRNA | CTD | PMID:27188386 | valproic acid | increases methylation | ISO | SCML1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SCML1 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in decreased expression of SCML1 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | valproic acid | affects expression | ISO | SCML1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SCML1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SCML1 mRNA | CTD | PMID:19101580 more ... | vitamin E | decreases expression | ISO | SCML1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | vitamin E | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA | CTD | PMID:19244175 | vorinostat | increases expression | ISO | SCML1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of SCML1 mRNA | CTD | PMID:27188386 | zinc atom | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SCML1 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | SCML1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SCML1 mRNA | CTD | PMID:18593933 | |